QuiaPEG Pharmaceuticals Holding
0,03SEK -6,56%Vær den første som følger denne virksomhed
QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
QUIA
Daglig lav / høj pris
0,029 / 0,033
SEK
Markedsværdi
1,23 mio. SEK
Aktieomsætning
24,02 t SEK
Volumen
790 t
Finanskalender
Ekstraordinær generalforsamling
11.12.2023
Årsrapport
26.02.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Rothesay Jersey Limited | 11,7 % | 11,7 % |
| Gryningskust Holding AB | 10,1 % | 10,1 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper